Best Grants for Digestive System Health and Diseases in Arizona

The Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs) program invites applications to enhance communication and collaboration among researchers in digestive and liver diseases. Funded by the NIDDK, DDRCCs focus on shared resources that foster productivity and innovative research ideas. Each center must revolve around a central theme aligned with the NIDDK's mission, ensuring effective research support while avoiding overlap with other NIH Institutes' funding areas.

The NIDDK is expanding its Gastroparesis Consortium into the Disorders of Gastrointestinal Interoception Consortium (DGIC) to explore various GI disorders linked to interoceptive processing. This initiative aims to include multiple Clinical Research Centers and a Scientific Data Research Center, focusing on multidisciplinary approaches to uncover mechanisms connecting GI function to symptoms. The effort seeks to identify biomarkers and novel therapeutic targets for future clinical trials, enhancing understanding and treatment of complex gastrointestinal conditions.

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) aims to enhance understanding of inflammatory bowel diseases (IBD) through genomic research. By leveraging patient cohorts and advanced data science, the IBDGC seeks to identify genetic risk factors and develop predictive biomarkers for disease outcomes. This initiative will improve medical management and advance precision medicine for IBD patients, addressing the need for effective diagnostics and treatment strategies in this chronic condition.

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center aims to enhance understanding of inflammatory bowel disease (IBD) by coordinating extensive genetic research. By leveraging diverse patient cohorts and advanced data science techniques, the center seeks to identify genetic risk factors, develop predictive biomarkers, and improve IBD patient management. This initiative will facilitate collaboration among various research centers and ensure efficient data collection and sharing to foster advancements in precision medicine for IBD.

The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC) aims to enhance understanding of gastrointestinal disorders by expanding the previous Gastroparesis Consortium's research scope. This initiative will include adult and pediatric conditions linked to impaired interoceptive processing, utilizing multidisciplinary approaches to uncover mechanisms connecting GI function to symptoms, identify biomarkers for treatment efficacy, and explore new therapeutic targets for future clinical trials.

The NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional) program invites applications to support innovative biomedical research focused on cystic fibrosis, diabetes, and other chronic diseases. These centers foster collaboration, provide essential resources, and mentor early-stage investigators, enhancing the research landscape. Funding will support pilot programs and access to shared services, ensuring efficient use of resources while promoting a robust scientific community dedicated to advancing health outcomes.

American Gastroenterological Association

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization.

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

This award provides funding for three years to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in inflammatory bowel disease (IBD) research.

Objective

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). This award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research pertaining to inflammatory bowel disease.

Review all of the benefits AGA Research Scholar Award recipients are entitled to on the award policies page.

Application Requirements

• Maintain AGA membership throughout the three-year duration of the award.

• Applicants must self-assign their proposal to one of the following categories:
  • Clinical: Research involving direct contact with human subjects or using clinical data to address problems related to the prevention, diagnosis, treatment or outcome of human diseases (e.g., clinical epidemiology). This category also includes research related to health care delivery (e.g., health services, health IT).
  • Basic/Translational: Research with a primary goal of understanding basic biology or disease mechanisms. This category can involve animal subjects, cell culture, human biospecimens or human data as resources for laboratory- or informatics-based investigation.

• Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 50 percent effort to the proposed project.

• Applicants are required to have a sponsor and mentor for the award; one individual may serve in the capacity of both positions. A sponsor (typically a division chief or department chair) is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables and will work with the applicant to create a research career development plan.

• The intent of this award is to foster the scientific independence of junior investigators. Applicants whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It must also be clearly stated how the work submitted by the applicant is that of the applicant and not that of the senior mentor(s).

• A complete research facilities and resources form must be submitted.

• Biographical sketches for the applicant, mentor and other key personnel must be submitted.

• Applicants resubmitting a revised application from a prior cycle must include a resubmission report describing responses to reviewer feedback and other major changes since the most recent past submission.

• Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee(s) for use of human subjects or animals. If approval is not necessary, then the recipient must provide documentation from the appropriate regulatory committee.

• Recipients must submit scientific and financial progress reports to AGA annually and final reports 60 days after the end date of the award period. Report templates and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.

• All publications, presentations, abstracts, and patent applications arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.

• Additional pre-award policies are available on the Research Award Policies page.

Award Overlap

• At the time of application submission, applicants may not hold, or have held, an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (e.g., the American Liver Foundation, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation).

• Applicants who have held a K12 or KL2 in the past are eligible to apply. Applicants with an active K12 or KL2 may apply in the final year of their active K12 or KL2 so long as the award will end before the Research Scholar Award term begins.

• If a applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, then the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

• If the recipient is notified that a comparable award has been granted after the first payment of this award, then the recipient may retain up to 50 percent of the remainder of his or her AGA award. AGA must be notified by the recipient via email within two weeks of receiving notification of additional funding.

Amgen is a leading biotechnology company dedicated to advancing medicine through Independent Medical Education (IME). It funds accredited educational programs that empower healthcare providers to enhance patient care. IME funding supports critical areas such as oncology, bone health, cardiovascular education, and more. Amgen's commitment ensures that these educational activities remain unbiased and compliant with applicable guidelines, fostering innovation and improved health outcomes for patients worldwide.

The AGA: Student Abstract Award offers a $500 travel grant to graduate students, medical students, and residents (up to postgraduate year three) presenting at Digestive Disease Week® (DDW). It aims to inspire interest in gastroenterology research by recognizing outstanding abstracts, with the top scorer honored as the Student Abstract of the Year and awarded an additional $1,000. Applicants must be sponsored by an AGA member and may only submit one abstract.

Medtronic is a global leader in medical technology, dedicated to enhancing healthcare access and supporting the communities it serves. Through its Grants and Donations program, Medtronic provides financial assistance for medical education, independent conferences, and charitable events, emphasizing collaboration with healthcare stakeholders. The program aims to alleviate pain, restore health, and extend life, positively impacting millions of patients worldwide. For more information, visit Medtronic's FAQs on grants and donations.

The Biocodex Microbiota Foundation invites early career researchers in the microbiome field from U.S. institutions to apply for the 2024 grant. This initiative focuses on groundbreaking research into gut microbiota's role in human health and disease, particularly in areas like circadian rhythms and metabolic disorders. The grant supports operational costs, allowing for innovative projects aimed at fostering independent research careers in microbiota studies.

The AGA Research Scholar Award offers $100,000 per year for three years to early-career faculty in digestive disease research. Applicants must hold an MD or PhD and be in a full-time faculty position in North America. The award fosters scientific independence by requiring a minimum of 50% research effort. AGA membership is mandatory, and applicants are encouraged to self-assign their proposals to specific research categories. This award aims to support promising junior researchers in their pursuit of independent research careers.

The AGA Fellow Abstract Award, offered by the American Gastroenterological Association, provides a $500 travel award to MD, PhD, or equivalent fellows who present their abstracts at Digestive Disease Week® (DDW). The award encourages the participation of active trainee members and emphasizes diversity by inviting applications from underrepresented groups in biomedical research. The top abstract will earn an additional $1,000 award, highlighting excellence in gastroenterology research.

The AGA Pilot Research Award offers $40,000 for one year to independent investigators at any career stage, focusing on innovative research in gastroenterology or hepatology. Applicants must hold an MD, PhD, or equivalent degree, and AGA membership is required at the time of application. This award encourages early career researchers and supports projects with new directions, emphasizing mentorship for those in the early stages of their careers.

The Dr. Harvey Young Education & Development Foundation’s Young Guts Scholars Program supports undergraduate students from underrepresented groups in biomedical research. The program encourages students to pursue careers in science or medicine by offering a stipend, AGA membership, and travel funds for Digestive Disease Week®. Eligible applicants must have a mentor and commit to a minimum of 12 hours of research per week. This initiative aims to expand the pipeline of investigators in digestive disease research.

The AGA Abstract Award for Health Disparities Research provides a $500 travel grant for graduate students, medical students, residents, clinical fellows, and postdoctoral fellows who present research on health disparities at Digestive Disease Week® (DDW). This award aims to enhance interest in gastroenterology research and improve access to care for underserved populations. It recognizes outstanding abstracts accepted by AGA, fostering future careers in digestive disease research among young professionals.

The Research Foundation of the American Society of Colon and Rectal Surgeons offers a Career Development Award to support early career investigators in colorectal surgery. With a funding of $75,000 per year for two years, this award emphasizes mentorship and career growth. Applicants must be within five years of their first faculty position and demonstrate innovative research in colon and rectal diseases. The award aims to enhance academic careers while fostering advancements in surgical techniques.

This program aims to enhance education for healthcare professionals regarding new therapies and patient management in ulcerative colitis (UC). It focuses on multi-channel educational strategies to address the evolving landscape of UC treatment. Key areas include educating on new oral therapies, transitioning to advanced therapies, and managing isolated proctitis. Organizations such as healthcare institutions and medical education companies are eligible to apply, ensuring a comprehensive approach to improving UC care.

The Therapeutic Giving program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatment and advance health equity, particularly in immunology. Eligible nonprofit organizations can apply for support aimed at improving health outcomes through innovative programs. The initiative prioritizes measurable impacts over fundraising activities, emphasizing the importance of addressing healthcare disparities and promoting disease awareness efforts for diseases like rheumatoid arthritis and psoriasis.

The Stanford Children's Health Center for IBD and Celiac Disease offers Intramural Seed Grants to promote innovative research in pediatric diseases. This program supports high-risk, high-reward projects, encouraging multi-PI collaborations across disciplines. Awards of up to $100,000 per year for two years are available, aimed at generating preliminary data for future funding applications. Eligible applicants include Stanford faculty holding specific university positions. Proposals should focus on advancing understanding of pediatric IBD and celiac disease through various research approaches.

The Aman Armaan Ahmed Family SURF for Success Program offers summer undergraduate research fellowships for students from underrepresented groups in biomedical research. Awardees engage in 10 weeks of research related to digestive diseases under expert mentorship, receiving a stipend of $6,200. This initiative aims to inspire students to pursue careers in science and medicine, enhancing diversity in the field of gastroenterology and hepatology.

The AGA Fellowship-to-Faculty Transition Award offers $65,000 per year for two years, totaling $130,000, to clinical and postdoctoral fellows. This funding is intended to support their transition to independent research careers focused on inflammatory bowel disease in gastroenterology. Applicants must hold an MD or equivalent, be in a fellowship position in North America, and demonstrate a commitment to clinical or translational research. AGA membership is required, and applicants should have a mentor who is also an AGA member.

The NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34) aims to support high-risk, multi-center clinical studies by facilitating early peer review and assessment of study designs. This program helps in the development of necessary operational documents and essential elements for conducting hypothesis-driven studies focused on diseases relevant to NIDDK. Applications are due by 5:00 PM local time, and consulting with NIDDK staff is strongly encouraged.

The Stanford Medicine Children’s Health Center for IBD and Celiac Disease offers funding for postdoctoral fellows and instructors to conduct innovative research focused on pediatric IBD and celiac disease. This initiative aims to nurture future researchers and prepare them for independent funding opportunities. Eligible research includes basic, clinical, epidemiological, and health policy studies related to maternal and child health. Funding supports substantial salary and benefits, ensuring commitment to impactful research in this critical area.

The J.W. Couch Foundation Grant focuses on supporting Wildlife Conservation nonprofit organizations that align with their mission of community betterment and environmental protection. The foundation seeks partnerships with organizations that promote animal wellbeing, early childhood education, teacher support, and outdoor activities. Eligible applicants must be registered 501(c)3 nonprofits or for-profit entities aligned with their charitable programs. This grant emphasizes collaboration and community engagement to create lasting impacts.

The Mutual of America Foundation Community Partnership Award honors exemplary nonprofit organizations in the U.S. that foster collaborative partnerships across sectors. Annually, a national competition showcases numerous organizations demonstrating impactful community partnerships. Six organizations receive recognition, including the Thomas J. Moran Award, which offers $100,000, and the Frances R. Hesselbein Award, granting $75,000. Since 1996, the award has acknowledged 262 partnerships, emphasizing Mutual of America's commitment to societal improvement through collaboration.

The Spark Good: Strengthening Community Local Grants program by the Wal-Mart Foundation empowers local organizations through grants ranging from $250 to $5000. This initiative aims to enhance community welfare by supporting diverse projects, including animal shelters and educational programs. Eligible organizations must have a verified Spark Good account, ensuring funds are allocated effectively to meet local needs and foster community development. Together, we can create lasting impacts through small yet significant actions.